(Q57666978)
Statements
A phase II−III trial of olesoxime in subjects with amyotrophic lateral sclerosis (English)
0 references
21 January 2014
0 references
21
0 references
3
0 references
529-536
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference